Alyeska Investment Group, L.P. Rhythm Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $1.32 Million - $2.58 Million	65,367 Added 760.97%	73,957 $1.57 Million
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $2.66 Million - $3.53 Million	-98,517 Reduced 91.98%	8,590 $251,000
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $1.82 Million - $3.77 Million	107,107 New	107,107 $3.35 Million

193

67.1M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.3B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.